There was no significant difference in the rate of breast cancer in FIT : @ % ( n = @ ) in the placebo group and @ % ( n = @ ) in the alendronate group ( hazard ratio -LSB- HR -RSB- , @ -LSB- @ % CI , @-@ @ -RSB- ) .